U.S., April 19 -- ClinicalTrials.gov registry received information related to the study (NCT06933459) titled 'To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults' on April 11.
Brief Summary: To evaluate the safety and pharmacokinetic characteristics of AJU-C714 and C714R in healthy adults
Study Start Date: May 25
Study Type: INTERVENTIONAL
Condition:
Dyslipidemia
Intervention:
DRUG: AJU-C714
Ezetimibe 10mg, Rosuvastatin 20mg
DRUG: C714R
Ezetimibe 10mg, Rosuvastatin 20mg
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AJU Pharm Co., Ltd.
Disclaimer: Curated by HT Syndication....